Antibiotic policy: Why and for whom?

Journal International Medical Sciences Academy

Volumn 17, Issue 3, 2004, Pages 170-173

  Wattal, Chand ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG MISUSE; DRUG USE; HOSPITAL; IN VITRO STUDY; MEDICAL AUDIT; MICROBIOLOGY; PHARMACODYNAMICS; PHARMACOKINETICS; POLICY; PREDICTION; PRESCRIPTION; RATIONAL ANTIBIOTIC USE; REVIEW;

EID: 14744282594     PISSN: 0971071X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Polk R. Optimal use of modern antibiotics: Emerging trends. Clin Infect Dis 1999;29:264-74.
2. Guillemot D, Maison P, Carbon C, et al. Trends in antimicrobial use in the community France, 1981-1992. J Infect Dis 1998;177:492-7.
3. Gonzalez R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
4. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245-52.
5. Bantar C, Sartori B, Saul M, Salamone F, Vesco M, Morera G. Alarming misuse of antibiotics in a hospital from Argentina (abstract A-69). In: Program and abstracts of the 101st General Meeting of The American Society for Microbiology (Orlando, Florida). Washington, DC: American Society for Microbiology; 2001:17.
6. Beilby J, Marley J, Walker D, Chamberlain N, Burke M. Effect of changes in antibiotic prescribing on patient outcomes in a community setting: A natural experiment in Australia. FIESTA Study Group. Clin Infect Dis 2002;34:55-64.
7. Barenfanger J, Short MA, Groesch AA. Improved antimicrobial interventions have benefits. J Clin Microbiol 2001;39:2823-8.
8. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997;24:471-85.
9. Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consultant team. Pharmacotherapy 1999;19:1369-77.
10. Bantar C, Famiglietti A, Goldberg M. Three year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000;4:85-90.
11. Bustos J, Vesco E, Tosello C, et al. Alarming baseline rates of nosocomial infection and surgical prophylaxis errors in a small teaching hospital from Argentina. Infect Control Hosp Epidemiol 2001;22:264-5.
12. Burke A. Cunha. Antibiotic resistance. Medital Clini North Am 2000;84:1407-29.
13. Garau J. Treatment of drug resistant pneumococcal pneumonia. Lancet Infect Dis 2002;2:404-15.
14. Chandel DS, Choudhary R. Enteric fever treatment failures: A global concern. Emerg Infect Dis 2001;7:762-3.
15. Lee J, Carlson JA, Chamberlain MA. A team approach to hospital formulary replacement. Diagn Microbiol Infect Dis 1995;22:239-42.
16. Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use of a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997;16:904-12.
17. De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF. Improving the quality of antibiotic prescription patterns in general practice: The role of educational intervention. Med J Aust 1994;160:502-5.
18. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999;43:1379-82.
19. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000;21:455-8.